Chengchen Zhao1,2, Chunna Jin1,2, Xiaopeng He1,2, Simin Meng1,2, Qi Liu3, Zhongqi Zhang3, Jianzhong Sun4, and Meixiang Xiang4
1Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China, 2Key Lab of Cardiovascular Disease of Zhejiang Province, Hangzhou, China, 3UIH America, Inc., Houston, TX, United States, 4Department of Radiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
Synopsis
Keywords: Arrhythmia, Arrhythmia
CMR multitasking T1 mapping, a recently
proposed free-breathing, non-ECG technique, was evaluated in atrial
fibrillation patients. It demonstrated good image quality, differentiated
patients from healthy participants, and correlated with important cardiac
function biomarkers. It is a promising T1 mapping tool in atrial fibrillation patients.
Background
Cardiovascular magnetic resonance (CMR) T1 mapping provides
valuable information in myocardium abnormalities [1-3]. Atrial fibrillation
(AF) is associated with high morbidity and mortality. AF patients are
characterized by poor health conditions, inability to hold breath, and irregular
heart rhythm and short R-R intervals that disturb signal acquisition in the
optimal cardiac phase [4,5]. These made T1 mapping using the gold standard modified
look-locker inversion recovery (MOLLI) sequence challenging [6].
Recently, a free-breathing, non-ECG technique using multitasking
was proposed for cardiac-phase-resolved myocardial T1 mapping [7]. The authors hypothesized
that this technique may benefit participants with arrhythmia but conducted no
study.
The purpose of this
prospective study was to evaluate MR multitasking T1 mapping in AF. Method
Phantoms:
The T1 array in an ISMRM/NIST system phantom was used to assess
T1 mapping accuracy [8].
Participants:
34 AF patients and 21 healthy volunteers were recruited after
written consent. Patients were eligible if they were diagnosed with AF
regardless of the cause and had not yet received catheter ablation or pacemaker.
The exclusion criteria were age < 18 years, hemodynamically unstable, unable
to finish scan, and severe renal abnormality. Local IRB approved the study.
MRI protocols:
MRI was performed on a 3T system (uMR 790, United Imaging,
Shanghai, China). Multitasking
sequence was the same as previously published [7]. Short-axis T1 mapping by MOLLI and multitasking used 3 matched
slices. Cardiac functions were assessed on retrospectively gated cine images. Two
patients received 0.2 mmol/kg gadodiamide (MultiHance, Bracco Sine, China) and underwent
phase-sensitive-inversion-recovery (PSIR) scans. Five patients repeated the study
on the same day. MRI parameters are listed in Table 1.
Image analysis:
One radiologist analyzed the images using Cvi42 (Circle
Cardiovascular Imaging Inc., Calgary, Canada). Myocardial T1 values were
measured from ROIs drawn in the short‐axis slices. Papillary muscles and blood-pool were avoided.
Average T1 values of the basal, mid, and apical slices was defined as the mean
value. Left ventricle (LV) and left atrium (LA) function metrics and strains were
analyzed by standard techniques.
Non-MRI biomarkers:
An echocardiogram scan was performed on the same day as MR. Laboratory
results were collected from the patients before discharge.
Statistical analysis:
Categorical and consecutive data were presented as mean ±
standard deviation (normal distribution), or median ± quartile (not normal
distribution). Differences were tested by paired t-test or Kruskal-Wallis test.
Bland‐Altman analysis and Pearson
correlation were used. Correlation analysis was performed between select biomarkers
and multitasking T1 values. Intra-observer repeatability was assessed using
intraclass correlation coefficient (ICC). Statistical significance was defined as
p < 0.05.Results
Demographic information and biomarker results are listed in
Table 2. The echocardiogram revealed an enlarged LA dimension, in agreement
with MR findings that AF group had a higher LA volume than the healthy group.
Both MOLLI and multitasking correlated strongly (R=0.99,
p<0.001 for both) with the phantom T1 values.
Multitasking T1 exhibited a significant difference (p<0.001)
between the AF (1161.1 ±54.1 ms) and the healthy (1104.8 ±48.6 ms) groups. Similarly,
MOLLI T1 mapping exhibited a significant difference (p<0.001) between the AF
(1166.5 ±74.8 ms) and the healthy (1104.8 ±45.9 ms) groups.
Typical multitasking images
are shown in Figure 1A. AF multitasking images were free of artifacts and
displayed consistent LV inner diameter that indicates the same cardiac phase,
while MOLLI had artifacts and changing diameter that implies miss-triggering
and possible erroneous T1 fitting (Figure 1B).
Comparison between multitasking and MOLLI are shown in Figure 2.
Bland‐Altman analysis showed
all but one subjects were within the 95% limits of agreement in healthy
subjects, with the mean bias being 95.06 ms. Pearson correlation showed a
moderate correlation (R=0.47, p=0.030). All but two subjects in AF were within
the 95% limit, with the mean bias being 166.69 ms. There was non-significant
correlation (R=0.16, p=0.370). Paired-t test of each segment demonstrated
non-significant difference (p>0.05).
The correlations between select heart function biomarkers and
multitasking T1 values are shown in Figure 3. Increased multitasking T1 values were
associated with worsened heart failure.
Among the AF patients received contrast agents, cardiac lesion
of similar size and location was identified on multitasking, PSIR, and MOLLI images
(Figure 4).
Intra-observer repeatability (Figure 5) had a good intraclass
correlation coefficient (0.587 [0.587;0.837], p<0.001). It demonstrated a
low mean bias (65.45 ms) and high correlation between scans (R=0.89, p=0.042),
indicating good repeatability.Conclusion and Discussion
This study investigated the use of MR multitasking T1 mapping in
patients with AF. There was a significant native T1 value difference between AF
participants and healthy participants. Elevated native T1 value in MR
multitasking was associated with worsened cardiac function biomarkers. MR
multitasking T1 mapping, a technique requires no ECG trigger or breath-hold, is
promising for AF diagnosis.
Several factors could complicate the analysis of our results. 1)
MOLLI is known to underestimate myocardium T1 and thus create a bias. 2) As
been shown, MOLLI in AF is susceptible to artifacts stemming from
miss-triggering. This could explain the poor association between multitasking
and MOLLI in AF patients. 3) MR multitasking T1 mapping is sensitive to B1+
field inhomogeneity. A recently developed dual flip-angle technique with spin
history mapping is expected to alleviate this problem [9]. Acknowledgements
No acknowledgement found.References
[1] January,
C.T., et al., 2019. AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS
Guideline for the Management of Patients with Atrial Fibrillation: A Report of
the American College of Cardiology/American Heart Association Task Force on
Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With
the Society of Thoracic Surgeons. Circulation, 2019. 140(2): p. e125-e151.
[2] Neilan,
T.G., et al., The incidence, pattern, and prognostic value of left ventricular
myocardial scar by late gadolinium enhancement in patients with atrial
fibrillation. J Am Coll Cardiol, 2013. 62(23): p. 2205-14.
[3] Kato, S.,
et al., Left ventricular native T1 time and the risk of atrial fibrillation
recurrence after pulmonary vein isolation in patients with paroxysmal atrial
fibrillation. Int J Cardiol, 2016. 203: p. 848-54.
[4] Zhao, L.,
et al., Systolic MOLLI T1 mapping with heart-rate-dependent pulse sequence
sampling scheme is feasible in patients with atrial fibrillation. J Cardiovasc
Magn Reson, 2016. 18: p. 13.
[5] Zhao, L.,
et al., Cardiovascular magnetic resonance-determined left ventricular
myocardium impairment is associated with C-reactive protein and ST2 in patients
with paroxysmal atrial fibrillation. J Cardiovasc Magn Reson, 2021. 23(1): p.
30.
[6] Messroghli, D.R., et al., 2004. Modified Look-Locker inversion
recovery (MOLLI) for high-resolution T1 mapping of the heart. Magnetic
resonance in medicine, 52(1), 141–146.
[7] Shaw, J. L., et al, 2019. Free-breathing, non-ECG, continuous
myocardial T1 mapping with cardiovascular magnetic resonance multitasking.
Magnetic resonance in medicine, 81(4), 2450–2463.
[8] Keenan, K.,
et al., Comparison of T1 measurement using ISMRM/NIST system phantom. 2016,
Proceedings of the International Society of Magnetic Resonance in Medicine,
Singapore.
[9] Serry FM, Ma S, Mao X, et al. Dual flip-angle IR-FLASH with
spin history mapping for B1+ corrected T1 mapping: Application to T1
cardiovascular magnetic resonance multitasking. Magn Reson Med.
2021;86(6):3182-3191.